Anavex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.

About AVXL

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. 

CEO
Christopher U. Missling
CEOChristopher U. Missling
Employees
42
Employees42
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2004
Founded2004
Employees
42
Employees42

AVXL Key Statistics

Market cap
279.15M
Market cap279.15M
Price-Earnings ratio
-5.75
Price-Earnings ratio-5.75
Dividend yield
Dividend yield
Average volume
6.02M
Average volume6.02M
High today
$3.37
High today$3.37
Low today
$3.12
Low today$3.12
Open price
$3.17
Open price$3.17
Volume
2.80M
Volume2.80M
52 Week high
$14.44
52 Week high$14.44
52 Week low
$2.86
52 Week low$2.86

Stock Snapshot

Anavex(AVXL) stock is priced at $3.25, giving the company a market capitalization of 279.15M. It carries a P/E multiple of -5.75.

As of 2025-11-21, Anavex(AVXL) stock has fluctuated between $3.12 and $3.37. The current price stands at $3.25, placing the stock +4.2% above today's low and -3.6% off the high.

The Anavex(AVXL)'s current trading volume is 2.8M, compared to an average daily volume of 6.02M.

During the past year, Anavex(AVXL) stock moved between $2.86 at its lowest and $14.44 at its peak.

During the past year, Anavex(AVXL) stock moved between $2.86 at its lowest and $14.44 at its peak.

AVXL News

Simply Wall St 5d
Why Anavex Life Sciences Is Down After an EMA Setback for Its Alzheimer’s Drug Application

Anavex Life Sciences recently reported that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative trend vote on the c...

Why Anavex Life Sciences Is Down After an EMA Setback for Its Alzheimer’s Drug Application

People also own

Based on the portfolios of people who own AVXL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.